DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pred-Mild (Prednisolone Acetate Ophthalmic) - Published Studies

 
 



Pred-Mild Related Published Studies

Well-designed clinical trials related to Pred-Mild (Prednisolone Ophthalmic)

A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery. [2011.10]

Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. [2011.01]

Methylprednisolone applied directly to the round window reduces dizziness after cochlear implantation: a randomized clinical trial. [2011]

Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. [2010.10]

Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. [2010.05]

Effect of oral prednisolone on visual outcomes and complications after scleral buckling. [2010.03]

Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. [2009.01]

Efficacy of methylprednisolone injected into the masseter muscle following the surgical extraction of impacted lower third molars. [2008.03]

Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. [2008.02]

Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. [2007.10]

High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.09]

Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. [2007.09]

Side effects of postoperative administration of methylprednisolone and gentamicin into the posterior sub-Tenon's space. [2007.05]

High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.01.31]

Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. [2007.01]

Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. [2006.02]

[Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis] [2005.09]

Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]

Well-designed clinical trials possibly related to Pred-Mild (Prednisolone Ophthalmic)

Visual outcomes in treated bacterial keratitis: four years of prospective follow-up. [2014]

The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. [2014]

Anti-inflammatory therapy after selective laser trabeculoplasty: a randomized, double-masked, placebo-controlled clinical trial. [2014]

The incidence of acute anterior uveitis after intravenous zoledronate. [2013]

Nocardia keratitis: clinical course and effect of corticosteroids. [2012]

Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. [2012]

Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). [2012]

Corticosteroids for Bacterial Keratitis: The Steroids for Corneal Ulcers Trial (SCUT). [2011.10.10]

Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. [2011.09]

Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. [2011.05.25]

The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. [2011.04]

Influence of systemic steroids on subretinal fluid after scleral buckle surgery for macula-off retinal detachment. [2011.01]

Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid. [2011]

Dynamic hyperinflation after metronome-paced hyperventilation in COPD--a 2 year follow-up. [2010.11]

Levodopa-carbidopa may improve vision loss in indirect traumatic optic neuropathy. [2010.10]

Orbital steroid injection versus oral steroid therapy in management of thyroid-related ophthalmopathy. [2010.10]

Long-term cancer risk of immunosuppressive regimens after kidney transplantation. [2010.05]

Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. [2010.03]

The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty. [2010.01]

Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study. [2010]

Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study. [2009.11]

A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. [2009.07]

Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]

Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. [2008.11]

Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. [2008.07]

Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial. [2008.07]

The treatment of giant cell arteritis. [2008.06]

Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. [2008.03]

Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]

[Basiliximab following penetrating risk-keratoplasty--a prospective randomized pilot study] [2008.01]

[Long-term results of FK 506 eye drops following corneal transplantation] [2008.01]

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]

Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. [2007.08]

Impact of short-term versus longterm topical steroid treatment on 'idiopathic' endothelial cell loss after normal-risk penetrating keratoplasty. [2007.03]

[Effects of acupuncture on the pulmonary function and heart rate variability in different state of bronchial asthma] [2007.02]

Single-dose oral dexamethasone in the emergency management of children with exacerbations of mild to moderate asthma. [2006.12]

Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. [2006.10]

Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. [2006.10]

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis. [2006.09]

Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. [2005.11]

Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. [2005.09]

Changes in bacterial and fungal ocular flora of clinically normal horses following experimental application of topical antimicrobial or antimicrobial-corticosteroid ophthalmic preparations. [2005.05]

[Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study] [2005.05]

Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. [2005.02]

Other research related to Pred-Mild (Prednisolone Ophthalmic)

Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. [2013]

Effects of one-week versus one-day preoperative treatment with topical 1% prednisolone acetate in dogs undergoing phacoemulsification. [2012]

Evaluation of Sustained Release of PLC-Loaded Prednisolone Acetate Microfilm on Postoperative Inflammation in an Experimental Model of Glaucoma Filtration Surgery. [2011.12]

Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy. [2011.06]

Difluprednate for inflammatory eye disorders. [2011.05]

Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. [2011.05]

Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay. [2011.02]

Effects of twice-daily topical difluprednate 0.05% emulsion in a child with pars planitis. [2011.02]

Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK. [2011]

Difluprednate for inflammatory eye disorders. [2011]

Intraocular pressure elevation from topical difluprednate use. [2010.12]

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. [2010.12]

A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes. [2010.10]

The role of intravenous methylprednisolone immunosuppression in the management of active thyroid eye disease. [2010.10]

Durezol((R)) (Difluprednate Ophthalmic Emulsion 0.05%) Compared with Pred Forte((R)) 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. [2010.09.01]

Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis. [2010.08.11]

The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy. [2010.08]

Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. [2010.07]

Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. [2010.06]

Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy. [2010.04.05]

Development of new ophthalmic suspension prednisolone acetate 1%. [2010.04]

Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy. [2010]

Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. [2010]

Comparison of orbital floor triamcinolone acetonide and oral prednisolone for cataract surgery management in patients with non-infectious uveitis. [2010]

Effect of oral prednisolone on visual outcomes and complications after scleral buckling. [2010]

Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation. [2009.12]

[Biodegradable systems containing prednisolone acetate for orbital administration] [2009.07]

Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy. [2009.05]

Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. [2009.03.01]

Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle. [2008.11]

Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats. [2008.11]

Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis. [2008.10]

Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2008.08]

Long term results of age-related macular degeneration therapy with prednisolone acetate--special refer to peripheral visual field changes. [2008.06]

Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. [2008.06]

Treatment of ocular inflammatory conditions with loteprednol etabonate. [2008.04]

Does in vitro susceptibility predict clinical outcome in bacterial keratitis? [2008.03]

Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. [2007.10]

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. [2007.09]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017